65--Single Cell RNA Sequencing Kits for NICHD Thyroid
ID: 75N94024Q00213Type: Presolicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH NICHDBETHESDA, MD, 20817, USA

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

PSC

IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS (6550)

Original Source

https://sam.gov/opp/abd8a345d0e945c8894b4fa43b45c0ad/view
Timeline
    Description

    The National Institutes of Health, National Institute of Child Health and Development (NICHD) plans to award a contract for Single Cell RNA Sequencing Kits to support thyroid hormone studies. This is a pre-solicitation notice, with the intent to award the contract without competition to 10X GENOMICS, INC.

    The NICHD invites capable and interested parties to submit responses outlining their qualifications and capacity to fulfill the requirement. The agency will consider the information received but maintains discretion on whether to proceed competitively or non-competitively.

    The opportunity seeks to procure single-cell RNA sequencing kits for research purposes. Respondents should have the capability to provide the required sequencing kits and ensure compliance with the specialized needs of thyroid hormone studies.

    To participate, interested parties must register in the System for Award Management (SAM) and submit their responses by the deadline. The primary contact for this opportunity is Jacob Balenson, whose email is provided in the listing.

    Please note that responses must be submitted electronically, following the specified format and deadline.

    Point(s) of Contact
    BALENSON, JACOB M
    (301) 827-8302
    jacob.balenson@nih.gov
    Files
    No associated files provided.
    Lifecycle
    Title
    Type
    65--Single Cell RNA Sequencing Kits for NICHD Thyroid
    Currently viewing
    Presolicitation
    Similar Opportunities
    Acquisition of a U-Rhythm Device for Endocrine and Metabolic Investigation
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking quotes for the acquisition of a U-Rhythm device intended for endocrine and metabolic research at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The procurement aims to obtain U-RHYTHM microdialysis collection devices, which are crucial for monitoring hormone levels in interstitial tissue fluid over extended periods in real-world settings, and includes essential components such as a portable syringe pump, microdialysis catheter, tubing assemblies, and processing kits. This equipment is vital for advancing scientific understanding and treatment options in endocrine and metabolic health. Interested vendors should contact Amber Harris at amber.harris@nih.gov for further details, as the solicitation is not set aside for small businesses and will be evaluated based on technical compliance and cost, with a Firm-Fixed Price purchase order to be delivered and accepted at the NIH facility in Bethesda, Maryland.
    Notice of Intent: Gemini Bio-GemCell TM Plus Xeno free Reagents
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) intends to award a sole-source contract to Gemini Bio for the supply of GemCell™ Plus Xeno-Free reagents, essential for the Center for Cellular Engineering's operations in Bethesda, Maryland. This procurement is critical as the Center relies on these specific reagents for manufacturing human cell and tissue-based products used in clinical trials, which are vital for patient care and treatment protocols. The unique compatibility of Gemini Bio's products with existing manufacturing processes makes them the only viable source, as switching vendors would incur significant costs and delays, potentially impacting patient outcomes. Interested parties may submit capability statements to Sheri Eiri at sheri.eiri@nih.gov by September 8, 2024, at 12:00 PM EST for consideration.
    Genomics Sequencing Services for the NIAID Centralized Sequencing Program
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) through the National Institute of Allergy and Infectious Diseases (NIAID), is seeking quotes for genomics sequencing services to support its Centralized Sequencing Program (CSP). The procurement aims to provide comprehensive whole genome sequencing, including variant interpretation and clinical reports, to enhance clinical research on infectious diseases, with results expected within four weeks of sample receipt. This initiative is critical for advancing the understanding of genetic factors in disease and improving patient care through genomic evaluations. Interested vendors must submit their quotes by 3:00 PM EST on September 13, 2024, to the primary contact, Seth Schaffer, at seth.schaffer@nih.gov, with the solicitation number RFQ-NIAID-24-2224314.
    66--HD-X02 Implants.
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for the procurement of HD-X02 Implants. This presolicitation opportunity falls under the NAICS code 334516, which pertains to Analytical Laboratory Instrument Manufacturing, and is classified under the PSC code 6640 for Laboratory Equipment and Supplies. The HD-X02 Implants are critical for advancing research and development in the biomedical field, supporting various health initiatives. Interested vendors can reach out to Noelle Decenzo at noelle.decenzo@nih.gov or call 301-402-5571 for further details regarding this opportunity.
    Next-Generation Sequencing (NGS) Liquid Handling Systems – Brand Name or Equal
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking quotes for two Next-Generation Sequencing (NGS) Liquid Handling Systems to enhance research capabilities at its Bethesda, Maryland campus. These systems are essential for high-throughput processing in infectious disease research, particularly for single cell-based antibody discovery and RNA/DNA processing, which are critical for pandemic preparedness. Interested vendors must submit their quotes by 12:00 pm EST on September 26, 2024, including detailed specifications and compliance with federal regulations, to Daveta H. Brown at daveta.brown@nih.gov.
    Sequencing reagents and flow cells
    Active
    National Aeronautics And Space Administration
    NASA's National Aeronautics and Space Administration (NASA) is seeking to procure sequencing reagents and flow cells, which are critical for RNA sequencing from various tissues collected during space missions. This procurement is part of the NASA GeneLab project, aimed at expanding the volume and utility of omics data from spaceflight experiments, and the reagents must be compatible with the Illumina NovaSeq 6000 platform to ensure effective library preparation and sequencing. The selected contractor will deliver the required reagents to the NASA Ames Research Center within 15 days post-contract award, with options for partial deliveries, emphasizing NASA's commitment to advancing biological research. Interested organizations must submit their capabilities and qualifications in writing to Sara Jusino-Terry at sara.a.jusino-terry@nasa.gov by 12 p.m. Central Standard Time on September 9, 2024, to be considered for this sole source contract with Illumina, Inc.
    PacBio Revio Reagents
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking procurement of PacBio Revio Reagents. This solicitation aims to acquire reagents that are critical for various analytical laboratory applications, particularly in the field of genomics and molecular biology. The goods are essential for conducting in vitro diagnostic tests, which play a significant role in research and clinical diagnostics. Interested vendors can reach out to Dorothy L. Maxwell at dorothy.maxwell@nih.gov or call 301-827-7729 for further details regarding the procurement process.
    SOURCES SOUGHT: Maintenance and Repair Service for the Nanopore Promethion Long Read Sequencer
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified vendors to provide maintenance and repair services for the Nanopore Promethion Long Read Sequencer. The primary objective is to ensure the reliable functioning of this critical laboratory equipment, which supports ongoing research at the National Institute on Aging, particularly in neurogenetics and Alzheimer's disease studies. The selected contractor will be responsible for preventative maintenance, software upgrades, and troubleshooting, with a requirement for OEM-certified parts and factory-trained technicians. Interested parties must submit their capability statements to Hashim Dasti at hashim.dasti@nih.gov by September 18, 2024, at 11 AM Eastern Time, adhering to specified formatting guidelines.
    DNA SEQUENCING SYSTEM MAINTENANCE SUPPORT AGREEMENTS
    Active
    Commerce, Department Of
    The Department of Commerce, specifically the National Institute of Standards and Technology (NIST), intends to negotiate a sole source contract for maintenance support agreements related to the Illumina MiSeq FGx DNA Sequencing System and its associated Data Analysis Server. The procurement aims to renew a Full Service Agreement and a Standard Service Agreement with Qiagen LLC, the only authorized service provider with certified engineers and OEM parts for this equipment. This maintenance support is crucial for ensuring the operational integrity and reliability of the DNA sequencing system, which plays a significant role in various scientific and research applications. Interested parties may express their interest and capability by contacting Randy E. Schroyer via email by 5:00 PM EST on September 10, 2024, as no formal solicitation package will be issued.
    Acquisition of Intravenous Stable Isotopes
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to acquire intravenous stable isotopes, namely 6,6 D2-glucose and D5 glycerol, for metabolic research purposes. This procurement is classified under NAICS code 325414 and is intended for a non-competitive contract with Pine Pharmaceuticals LLC, justified by the agency's determination that only this source can meet its specific needs. The isotopes are crucial for clinical studies, and the contract period is set from September 16, 2024, to September 15, 2025, with an estimated value below $250,000. Interested parties can reach out to Amber Harris at amber.harris@nih.gov for further inquiries regarding this opportunity.